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Submitted Jun 14, 2012; accepted Nov 16, 2012.DISCUSSIONDr Gustavo Oderich (Rochester, Minn). I would like to
congratulate you on a very important paper. I think the topic is
very pertinent now that we are exploring using lower-proﬁle stents
for infrarenal aneurysms. A little bit more about your method-
ology. Can you tell us whether you analyzed other thromboem-
bolic events in addition to the classic end point of limb
occlusion? It would be ideal for future comparisons with other
devices to have more granularity on thrombus formation and
changes in the ankle-brachial index. Also, have you evaluated
changes such as nonocclusive thrombus formation in the limbs
using repeated computed tomography (CT) scans?
Dr Laura van Zeggeren. Thank you. In this study, we
focused on patients who had a symptomatic obstruction, deﬁned
as clinical symptoms of limb ischemia in combination with
a complete occlusion of the endograft (body or a limb) or
stenosis. In the majority of patients, we found a complete occlu-
sion, but there were also patients who presented with claudica-
tion and who had a signiﬁcant stenosis or thrombus of one of
the graft limbs. Ankle-brachial index data were not available in
this study. We did not analyze CT scans of asymptomatic
patients for the presence of thrombus or stenosis in the current
study.
Dr Ian Loftus (London, UK). Can you tell us any more about
the native anatomy here as to whether these were predictable or
not? These are very high limb occlusion rates. If you included
the asymptomatic obstructions, this must be closer to 8%. So is
this a problem with the device or is it because the low proﬁle device
is pushing the boundaries of what you can treat?
Dr van Zeggeren. This is a very interesting question. In the
present study we only evaluated patients with a symptomatic
obstruction so we cannot say anything about the asymptomatic
obstruction rate. Now that we have found an endograft obstruc-
tion rate of 4.0%, it is indeed essential to further investigate
whether there is a relationship between complex anatomy and graft
obstruction and to identify other possible risk factors in order to
get a better understanding of the pathophysiology of graft obstruc-
tion and answer your last question.
Dr John Ricotta (Washington, DC). Did the patients who
obstructed have what looked like difﬁcult anatomy when you
looked at their preoperative CT scans?Dr van Zeggeren: We did look at the preoperative scans and
there certainly were patients with difﬁcult anatomy, but in this
stage of the study, we cannot statistically evaluate whether this is
a risk factor for obstruction because we did not evaluate CT scans
of patients without symptomatic obstructions. As mentioned
earlier, it is worthwhiledand we are aboutdto further investigate
this in order to extract predictive factors for obstruction and learn
more about patients and endografts at risk.
Dr Jean-Paul de Vries (Nieuwegein, The Netherlands). I am
the senior author of the manuscript. Approximately 30% of the
patients were treated outside the instructions for use, and this
was mainly because of the proximal infrarenal necks, with heavy
angulation, large diameter, or short necks. Concerning the access
arteries, perhaps a small percentage of the patients were outside
the instructions for use.
Dr Gale Tang (Seattle, Wash). Speaking to that, did you look
at how many of these devices were extended into the external iliac,
or were these patients with very small external iliac diameters?
Dr van Zeggeren. That is a good question, especially because
extension of the graft into the external iliac artery has been
described as risk factor for graft obstruction in the literature. In
a small percentage of patients in the obstruction group, there
was extension of the graft into the iliac artery. We did not have
data on the external iliac artery diameters of the whole population
or whether they were deployed in the external iliac artery and,
therefore, did not separately analyze this in the obstruction group.
However, we will more closely look at the iliac anatomy of the
patients in the obstruction group to get a better understanding
of possible risk factors that can be evaluated in the future.
Dr Edward Woo (Philadelphia, Pa). One other question:
You have a high majority of patients that you bailed out with
surgical methods. Were all of these patients attempted percutane-
ously ﬁrst; and if not, how come?
Dr van Zeggeren. Almost all of the patients who were treated
surgically were directly treated surgically. Four patients had ﬁrst an
endovascular attempt to treat the graft occlusion, but these were
not successful.
Dr Woo. Do you know why not?
Dr van Zeggeren. An attempt was made to start thromboly-
sis, but we could not pass the obstruction with guidewires.
